Related Experiment Video
Updated: Jul 19, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Association between coffee and incident heart failure: A prospective cohort study from the UK Biobank
Qiang Han1, Jiadong Chu1, Wei Hu1
1Department of Epidemiology and Biostatistics, School of Public Health, Medical College of Soochow University, Suzhou, 215123, China.
Insights
Moderate coffee consumption may lower heart failure risk. However, very high intake might increase risk, though this effect may not be significant in certain groups.
Area of Science:
- Cardiovascular epidemiology
- Nutritional science
- Public health
Background:
- The association between coffee intake and heart failure (HF) incidence remains unclear.
- Existing research has not fully addressed time-varying coffee consumption patterns.
- This study investigates the link between dynamic coffee consumption and new-onset HF.
Purpose of the Study:
- To examine the relationship between time-varying coffee consumption and incident heart failure.
- To clarify the dose-response association between coffee intake and HF risk.
- To explore potential modifying effects of factors like gender and smoking.
Main Methods:
- Utilized UK Biobank data from 497,503 adults, HF-free at baseline.
- Employed marginal structural models (MSM) to handle time-varying confounders and loss to follow-up.
- Applied restricted cubic splines to assess nonlinear relationships between coffee consumption and HF risk.
Main Results:
- A J-shaped, nonlinear association was observed between coffee consumption and HF risk (P < 0.001).
- Consuming 1-4 cups of coffee daily was linked to a reduced HF risk compared to less than 1 cup.
- >6 cups/day was associated with increased HF risk, but this was not significant in sensitivity analyses by gender or smoking status.
- Coffee type significantly influenced HF incidence (P < 0.05).
Conclusions:
- Moderate coffee consumption (1-4 cups/day) may be associated with a lower risk of heart failure incidence.
- High coffee consumption (>6 cups/day) may not significantly increase HF risk in certain subgroups.
- Coffee type is a significant factor in HF incidence.
Background And Aims:
The relationship between coffee consumption and heart failure (HF) incidence is inconclusive. This study aimed to explore the association between time-varying coffee consumption and incident HF using a longitudinal study design.
Methods And Results:
Data were obtained from the UK Biobank, comprising 497,503 adults (age, 56.5 ± 8.1 years; 54.6% women) who were free from HF at baseline in 2006-2010. The median follow-up time for the HF incidence was 11.9 years. Marginal structural models (MSM) were employed to adjust for potential time-varying confounders and account for bias caused by loss of follow-up. Furthermore, we used a restricted cubic spline to test and describe the nonlinear relationship between coffee consumption and HF risk. At baseline, 70.5% of participants reported drinking ≥1 cups/d coffee and 2.7% participants developed HF. After adjusting for potential confounders, we identified a nonlinear J-shaped association between coffee consumption and HF risk (P < 0.001). Compared with drinking coffee <1 cups/d, 1-2 cups/d (HR = 0.878; 95% CI: 0.838-0.920), 3-4 cups/d (HR = 0.920; 95% CI: 0.869-0.974) may be associated with a reduced risk of HF, while >6 cups/d (HR = 1.209; 95% CI: 1.056-1.385) may be associated with a higher risk of HF. However, sensitive analyses stratified by gender and smoking status indicated that >6 cups/d does not significantly increase the risk of HF. Additionally, the type of coffee was found to significant impact on the incidence of HF (P < 0.05).
Conclusion:
In this large cohort of UK adults, moderate coffee consumption may reduce risk of HF incidence.
More Related Videos
Related Concept Videos
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Heart Failure IV: Classification and Diagnostic Evaluation
Pathophysiology of Heart Failure
Heart Failure III: Clinical Manifestations
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

